Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Current Opinion in Virology|March 14, 2022
The road to effective and accessible antibody therapies against Ebola virusHugues Fausther-Bovendo, Gary KobingerHuman Vaccines & Immunotherapeutics|December 9, 2014
Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?Hugues Fausther-Bovendo, Gary P KobingerCurrent Opinion in Virology|May 8, 2012
Ebolavirus vaccines for humans and apesHugues Fausther-Bovendo, Sabue Mulangu, Nancy J SullivanJournal of Acquired Immune Deficiency Syndromes (1999)|February 12, 2010
Specific phenotypic and functional features of natural killer cells from HIV-infected long-term nonprogressors and HIV controllersVincent Vieillard, Hugues Fausther-Bovendo, Assia Samri, et al.Vaccines|February 24, 2024
Human Tick-Borne Diseases and Advances in Anti-Tick Vaccine Approaches: A Comprehensive ReviewMarie-Edith Nepveu-Traversy, Hugues Fausther-Bovendo, George Giorgi BabuadzePlos Pathogens|July 10, 2010
HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathwayHugues Fausther-Bovendo, Vincent Vieillard, Sandrine Sagan, et al.Scientific Reports|September 15, 2021
In vivo generation of collagen specific Tregs with AAV8 suppresses autoimmune responses and arthritis in DBA1 mice through IL10 productionMatthew Wade, Hugues Fausther-Bovendo, Marc-Antoine De La Vega, et al.The Journal of Infectious Diseases|June 4, 2015
Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection StudyJenna Aviles, Alexander Bello, Gary Wong, et al.Antiviral Research|April 5, 2024
Ebola-specific therapeutic antibodies from lab to clinic: The example of ZMappGary Wong, Kathrina Mae Bienes, Ara Xiii, et al.AIDS (London, England)|December 22, 2007
NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cellsHugues Fausther-Bovendo, Nadia Wauquier, Julien Cherfils-Vicini, et al.Pageof 5